GENE ONLINE|News &
Opinion
Blog

2021-06-15| IPOSpecial

Is the Path to Public Market Smooth? A Candid Discussion on SPACs

by Daniel Ojeda
Share To
There are multiple ways for a company to raise money, from venture capital to the public offering of common stocks. One method that has garnered a lot of attention recently is the Special Purpose Acquisition Company (SPAC).
Recognizing the prominent role of SPACs in shaping the growth of biotech companies, an expert panel shared their experiences at the BIO Digital 2021 conference. The panel comprised of:

GO Prime with only $1.49 now

LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top